Delivery Order SPE2DB20D1051-SPE2DB25FD7RC
Award Date
4/9/25
Potential Completion Date
4/10/25
Potential Value
$2.9K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,283.49 firm fixed-price delivery order is for the supply of 4,565,622,917 units of Vyvanse 40 mg capsules. The contract has an ultimate completion date of August 29, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop...
This federal contract award, with ID SPE2DB20D3505|SPE2DB25FU4K7, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The $2,742.33 firm fixed-price delivery order is for the supply of 4,567,986,289 units of the pharmaceutical product Vyvanse 20 mg capsules. The contract has an ultimate completion date of April 22, 2025 and was awarded on April 21, 2025. Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions...
This federal contract award is a delivery order (SPE2DB22D3301|SPE2DB25FX9EQ) from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 40 mg Vyvanse capsules. The $1,613.10 firm fixed-price contract has a completion date of January 30, 2025 and was awarded on January 29, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) worth $999,999,999 that AmerisourceBergen holds with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,399.72 firm fixed price delivery order contract is for the supply of 4,567,582,710 units of the medication Vyvanse 40 mg capsules. The contract has an ultimate completion date of March 17, 2025 and was awarded on March 14, 2025. This award is associated with a larger Indefinite Delivery Contract (IDC) valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,830.95 firm-fixed-price delivery order is for the supply of 4,566,340,680 units of the prescription drug Vyvanse 40 mg capsules. The contract has an ultimate completion date of November 6, 2024 and was awarded on November 5, 2024. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract...
This federal contract award, with ID SPE2DX22D0010|SPE2D825FFL06, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $48,794.80 firm fixed-price delivery order is for the supply of 4,568,136,457 units of the medication Vyvanse (40mg capsules). The contract has an ultimate completion date of May 6, 2025 and was awarded on May 5, 2025. This delivery order is part of Amerisourcebergen's larger...
The U.S. Defense Logistics Agency (DLA) has awarded a firm-fixed-price delivery order contract valued at $1,210.55 to AmerisourceBergen Drug Corp for the supply of 4,566,110,813 units of the prescription drug Vyvanse 40 mg capsules. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that the DLA Troop Support Medical has with AmerisourceBergen, valued at up to $999,999,999 through December 2025, for a comprehensive range of medical commodities to support military...
This federal contract award, issued by the Defense Logistics Agency (DLA), was granted to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,718.32 firm fixed-price delivery order is for the supply of 4,566,518,420 units of Vyvanse 40 mg capsules. The contract has an ultimate completion date of November 22, 2024 and was awarded on November 21, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) between...
This federal contract award, with ID SPE2DB20D7061|SPE2DB25FSMV6, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $5,641.78 firm fixed-price delivery order is for the supply of 4,567,909,420 units of the medication Vyvanse 40 mg capsules. The contract has an ultimate completion date of April 11, 2025 and was awarded on April 10, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Vyvanse 40 mg capsules. The $3,204.63 firm-fixed-price delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs...